Position in MRK
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$963,750
+$31,503 QoQ
Shares Held
7,500
-3.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#2,149
of 3,769 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PERKINS CAPITAL MANAGEMENT INC holds $15,153,316 across 7 Drug Manufacturers - General names. MRK ranks #3 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,680 | $10,411,053 | |
| 2 | ABBV |
AbbVie Inc.
|
5,307 | $1,335,453 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
7,500 | $963,750 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
7,216 | $911,669 | |
| 5 | PFE |
Pfizer Inc
|
33,759 | $812,916 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,180 | $413,711 | |
| 7 | JNJ |
Johnson & Johnson
|
1,200 | $304,764 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $963,750 | 7,500 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $932,247 | 7,750 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $921,025 | 8,750 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $734,387 | 8,750 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $692,650 | 8,750 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $942,480 | 10,500 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,044,540 | 10,500 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,220,770 | 10,750 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $1,476,315 | 11,925 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,613,088 | 12,225 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,332,769 | 12,225 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,217,383 | 11,825 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $1,364,486 | 11,825 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $1,258,061 | 11,825 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,323,078 | 11,925 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $1,026,981 | 11,925 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $1,096,319 | 12,025 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $986,651 | 12,025 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $921,596 | 12,025 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $921,975 | 12,275 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $954,626 | 12,275 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $946,280 | 12,275 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,004,094 | 12,275 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,059,686 | 12,775 | Shares | Sole | 2020-10-28 | |
| 2020-03-31 | $985,985 | 12,815 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||